3Checa JF, Bellentani S, Tiribelli C. Alcohol-induced liver disease: From molecular damage to treatment. Rev Med Chile, 2002, 130: 681-690.
4Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology, 2003, 37: 493-503.
5Monzoni A, Masutti F, Saccoccio G, Bellentani S,Tiribelli C, Giacca M. Genetic determinants of ethanol-induced liver damage. Mol Med, 2001, 7:255 -262.
6Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology, 1997, 26: 143-146.
7Stewart S, Jones D, Day CP. Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol Med, 2001, 7: 408-413.
8Grove J, Daly AK, Bassendine MF, Gilvarry E,Day CP. Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut, 2000, 46: 540-545.
9Jarvelainen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology, 2001, 33: 1148-1153.
10Starkel P, Bishop K, Horsmans Y, Strain AJ. Expression and DNA-binding activity of signal transducer and activator of transcription 3 in alcoholic cirrhosis compared to normal liver and primary biliary cirrhosis in humans. Am J Pathol, 2003,162: 587-596.
